Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 35 - Antineoplastic agents
Patents for A61P 35 - Antineoplastic agents (221,099)
12/2012
12/27/2012WO2012177844A2 Substituted imidazopyridinyl-aminopyridine compounds
12/27/2012WO2012177837A2 Novel maytansinoid derivatives with peptide linker and conjugates thereof
12/27/2012WO2012177725A1 Metalloenzyme inhibitor compounds
12/27/2012WO2012177714A1 Substituted 6-aza-isoindolin-1-one derivatives
12/27/2012WO2012177684A2 Use of caspase 3 activity and its inhibitors
12/27/2012WO2012177635A1 Metalloenzyme inhibitor compounds
12/27/2012WO2012177624A2 Focused radiation for augmenting immune-based therapies against neoplasms
12/27/2012WO2012177618A1 Prostaglandin receptor ep2 antagonists, derivatives, compositions, and uses related thereto
12/27/2012WO2012177606A1 Azetidinyl phenyl, pyridyl or pyrazinyl carboxamide derivatives as jak inhibitors
12/27/2012WO2012177603A2 Metalloenzyme inhibitor compounds
12/27/2012WO2012177440A1 Dosage and administration of anti-erbb3 antibodies in combination with paclitaxel
12/27/2012WO2012177100A2 Composition comprising phosphatidylcholine as an active ingredient for attenuating toxicity of anticancer agent
12/27/2012WO2012176952A1 Aptamer which selectively binds to erbb2 receptor and uses thereof
12/27/2012WO2012176878A1 Proteasome inhibitor
12/27/2012WO2012176823A1 Anti-cancer agent composition
12/27/2012WO2012176796A1 Method for amplifying nk cells
12/27/2012WO2012176779A1 Anti-erbb3 antibody
12/27/2012WO2012176765A1 Anti-human p-cadherin (cdh3) recombinant antibody
12/27/2012WO2012176651A1 Novel anti-tumor agent, and method for screening for novel anti-tumor agent
12/27/2012WO2012176282A1 Apoptosis-inducing agent
12/27/2012WO2012176175A1 New uses of nanog inhibitors and related methods
12/27/2012WO2012176123A1 3 - imidazolyl- indoles for the treatment of proliferative diseases
12/27/2012WO2012176015A1 Methods for treating uv-damaged skin and scc tumors and for removing tattoos with topical ingenol mebutate
12/27/2012WO2012176009A1 Treatment and prevention of diseases related to oxidative stress
12/27/2012WO2012175991A1 Fused pentacyclic anti - proliferative compounds
12/27/2012WO2012175973A1 Combination treatment comprising a hdac6 inhibitor and an akt inhibitor
12/27/2012WO2012175958A1 Albumin production and cell proliferation
12/27/2012WO2012175874A1 Use of a high-adcc anti-cd20 antibody for treating waldenström's macroglobulemia
12/27/2012WO2012175798A2 Combination therapy
12/27/2012WO2012175654A1 Tetraline sulfonamide derivatives for use in the treatment of proliferative disorders
12/27/2012WO2012175594A1 Wheat germ extract obtained by protease hydrolysis and medical use thereof
12/27/2012WO2012175591A1 Heterocyclyl aminoimidazopyridazines
12/27/2012WO2012175541A1 Deuterium-enriched 4-hydroxy-5-methoxy-n,1-dimethyl-2-oxo-n-[(4-trifluoro-methyl)phenyl]-1,2-dihydroquinoline-3-carboxamide
12/27/2012WO2012175522A1 Polymorphs of (s)-pyrrolidine-1,2-dicarboxylic acid 2-amide 1-({4-methyl-5-[2-(2,2,2-trifluoro-1,1-dimethyl-ethyl)-pyridin-4-yl]-thiazol-2-yl}-amide
12/27/2012WO2012175520A1 Hydroxy substituted isoquinolinone derivatives
12/27/2012WO2012175487A1 Cyclohexyl isoquinolinone compounds
12/27/2012WO2012175481A1 Compositions and methods for treating leukemia
12/27/2012WO2012175223A1 Cathepsin-binding compounds bound to a carrier and their diagnostic use
12/27/2012WO2012175168A1 7-azaindole derivatives suitable for treatment of cancers
12/27/2012WO2012175052A1 Sensitizer for reversing or reducing radiotherapy resistance in cases of esophageal carcinoma, screening method and use thereof
12/27/2012WO2012175047A1 Use of fluorine-containing, water-soluble platinum complex in preparing medications for preventing and treating tumors
12/27/2012WO2012175046A1 Use of water soluble platinum complex in preparing drugs for prevention and treatment of tumours
12/27/2012WO2012175045A1 Water-soluble fluorine-containing platinum coordination complex for tumour treatment and preparation method thereof
12/27/2012WO2012175044A1 Water-soluble platinum coordination complex for tumour treatment and preparation method thereof
12/27/2012WO2012175002A1 Derivate, preparation method and use of 10-methoxycamptothecine
12/27/2012WO2012174970A1 Use of pigr as molecular marker in early recurrence and/or metastasis of tumours and intervention target for anti-metastatic drugs
12/27/2012WO2012174730A1 Preparative method and use of zyj-d08a and its epimers as histone deacetylase inhibitors
12/27/2012WO2012174699A1 A series of ecteinascidins analogs with anti-tumor effect
12/27/2012WO2012154587A3 Methods for preventing toxic drug-drug interactions in combination therapies comprising anti-erbb3 agents
12/27/2012WO2012151559A3 Cytotoxic therapy by proton flux modulation
12/27/2012WO2012142604A3 Targeting deregulated wnt signaling in cancer using stabilized alpha-helices of bcl-9
12/27/2012WO2012142245A3 Peptide mimetic ligands of polo-like kinase 1 polo box domain and methods of use
12/27/2012WO2012141796A3 Prostate cancer therapy with hsp90 inhibitory compounds
12/27/2012WO2012135641A3 Aurora kinase inhibitors and methods of making and using thereof
12/27/2012WO2012135588A3 Methods of treating serosal cancer
12/27/2012WO2012135422A3 Thermo-sensitive, mucoadhesive or dermoadhesive, and penetration-enhancing formulations for topical delivery of therapeutics
12/27/2012WO2012135081A3 Lin28-mediated control of let-7 biogenesis
12/27/2012WO2012129564A3 Proteasome chymotrypsin-like inhibition using pi-1833 analogs
12/27/2012WO2012129335A3 Hyd1 peptides for relapsed cancer
12/27/2012WO2012128530A3 2-methyl-2-alkyl-6-amido-2h-benzopyran derivatives having anti-cancer activity
12/27/2012WO2012125573A3 Use of inhibitors of egfr-family receptors in the treatment of hormone refractory breast cancers
12/27/2012WO2012122513A3 Generation of anti-fn14 monoclonal antibodies by ex-vivo accelerated antibody evolution
12/27/2012WO2012108749A3 Composition and health functional food for treating brain cancer comprising pharbitidis semen extract
12/27/2012WO2012108748A3 Composition and cosmetic composition for treating brain cancer comprising albizzia julibrissin extract
12/27/2012WO2012108747A3 Composition and cosmetic composition for treating brain cancer comprising helena root extract
12/27/2012WO2012108745A3 Composition and health functional food for treating brain cancer comprising gleditsiae semen extract
12/27/2012WO2012108744A3 Composition and health functional food for treating brain cancer comprising inula flower extract
12/27/2012WO2012108743A3 Composition and cosmetic composition for treating brain cancer comprising white pharbitis seed extract
12/27/2012WO2012108742A3 Composition and health functional food for treating brain cancer comprising tussilago farfara l. flower extract
12/27/2012WO2012102753A3 Metalloproteinase oligopeptides and their therapeutic use
12/27/2012WO2012079088A3 Mimetic peptides derived from collagen type iv and their use for treating angiogenesis- and lymphangiogenesis- dependent diseases
12/27/2012WO2012075396A3 Prodrugs of 6-cyclohexyl-1-hydroxy-4- methylpyridin-2(1h)-one and derivatives thereof
12/27/2012WO2012071509A3 Benzoxazepines as inhibitors of p13k/mtor and methods of their use and manufacture
12/27/2012WO2012065139A8 Entpd5 inhibitors
12/27/2012WO2011115725A3 Indazole compounds as kinase activity modulators for the treatment of cancer and related disorders
12/27/2012US20120329990 B7-related nucleic acids and polypeptides useful for immunomodulation
12/27/2012US20120329880 Method of preparing oil suspensions of carotenoid with low viscosity and high fluidity and use thereof
12/27/2012US20120329878 Phenotyping tumor-infiltrating leukocytes
12/27/2012US20120329866 Therapeutic compounds
12/27/2012US20120329865 MOLECULES RELATED hERG ION CHANNELS AND THE USE THEREOF
12/27/2012US20120329864 Synergistic effect of tocotrienols and curcumin
12/27/2012US20120329863 Isolation of a dual cox-2 and 5-lipoxygenase inhibitor from acacia
12/27/2012US20120329861 Treatment of cancer using benzoic acid derivatives
12/27/2012US20120329860 Uses of Beta-Nicotinamide Adenine Dinucleotide
12/27/2012US20120329859 MicroRNA Fingerprints During Human Megakaryocytopoiesis
12/27/2012US20120329858 Modified oligonucleotides for telomerase inhibition
12/27/2012US20120329855 Treatment of hepatocyte growth factor (hgf) related diseases by inhibition of natural antisense transcript to hgf
12/27/2012US20120329854 Methods and Compounds for the Diagnosis and Treatment for Cancer
12/27/2012US20120329853 Microrna-based method for anti-colorectal cancer effects and prognosis of colorectal cancer
12/27/2012US20120329841 Treating cancer with desthiazolyl ritonavir
12/27/2012US20120329836 Methods for stabilizing hypoxia inducible factor-2 alpha as a method for treating cancer
12/27/2012US20120329826 Substituted-5-aminopyrrolo/pyrazolopyridines
12/27/2012US20120329822 10'-fluorinated vinca alkaloids provide enhanced biological activity against mdr cancer cells
12/27/2012US20120329819 New crystalline form of pemetrexed disodium
12/27/2012US20120329810 Imatinib mesylate oral pharmaceutical composition and process for preparation thereof
12/27/2012US20120329808 Dihydrothieno pyrimidines as akt protein kinase inhibitors
12/27/2012US20120329803 Dihydropteridinones, method for production and use thereof
12/27/2012US20120329802 Metalloenzyme inhibitor compounds
12/27/2012US20120329798 Methods and compositions for treating luekemia
12/27/2012US20120329795 Quinazoline derivatives
1 ... 235 236 237 238 239 240 241 242 243 244 245 246 247 248 249 250 251 252 253 254 255 ... 2211